Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Monitoring of risk perceptions and correlates of precautionary behaviour related to human avian influenza during 2006 - 2007 in the Netherlands: results of seven consecutive surveys

Authors: Onno de Zwart, Irene K Veldhuijzen, Jan Hendrik Richardus, Johannes Brug

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

Avian influenza (AI) is a public health challenge because of ongoing spread and pandemic potential. Non-pharmaceutical measures are important to prevent the spread of AI and to contain a pandemic. The effectiveness of such measures is largely dependent on the behaviour of the population. Risk perception is a central element in changing behaviour. This study aimed to investigate perceived vulnerability, severity and precautionary behaviour related to AI in the Netherlands during seven consecutive surveys in 2006 - 2007 as well as possible trends in risk perception and self-reported precautionary behaviours.

Methods

Seven web-based surveys were conducted including 3,840 respondents over a one-year period. Time trends were analyzed with linear regression analyses. Multivariate analysis was used to study determinants of precautionary behaviour.

Results

While infection with AI was considered a very severe health problem with mean score of 4.57 (scale 1 - 5); perceived vulnerability was much lower, with a mean score of 1.69. While perceived severity remained high, perceived vulnerability decreased slightly during a one-year period covering part of 2006 and 2007. Almost half of the respondents (46%) reported taking one or more preventive measures, with 36% reporting to have stayed away from (wild) birds or poultry. In multivariate logistic regression analysis the following factors were significantly associated with taking preventive measures: time of the survey, higher age, lower level of education, non-Dutch ethnicity, vaccinated against influenza, higher perceived severity, higher perceived vulnerability, higher self efficacy, lower level of knowledge, more information about AI, and thinking more about AI. Self efficacy was a stronger predictor of precautionary behaviour for those who never or seldom think about AI (OR 2.3, 95% CI 1.9 - 2.7), compared to those who think about AI more often (OR 1.5, 95% CI 1.2 - 1.9).

Conclusions

The fact that perceived severity of AI appears to be high and remains so over time offers a good point of departure for more specific risk communications to promote precautionary actions. Such communications should aim at improving knowledge about the disease and preventive actions, and focus on perceived personal vulnerability and self efficacy in taking preventive measures.
Appendix
Available only for authorised users
Literature
1.
Smith RD: Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Soc Sci Med. 2006, 63 (12): 3113-23. 10.1016/j.socscimed.2006.08.004.CrossRefPubMed
2.
Wallis P, Nerlich B: Disease metaphors in new epidemics: the UK media framing of the 2003 SARS epidemic. Soc Sci Med. 2005, 60 (11): 2629-39. 10.1016/j.socscimed.2004.11.031.CrossRefPubMed
3.
4.
5.
World Health Organization: Pandemic (H1N1) 2009 - update 59. Laboratory-confirmed cases of pandemic (H1N1) 2009 as officially reported to WHO by States Parties to the IHR (2005). 2009
6.
7.
Basili M, Franzini M: Understanding the risk of an avian flu pandemic: rational waiting or precautionary failure?. Risk Anal. 2006, 26 (3): 617-30. 10.1111/j.1539-6924.2006.00761.x.CrossRefPubMed
8.
Aledort JE, Lurie N, Wasserman J, Bozzette SA: Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007, 7 (147): 208-10.1186/1471-2458-7-208.CrossRefPubMedPubMedCentral
9.
Bell DM: Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis. 2006, 12 (1): 88-94.PubMed
10.
Bell DM: Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis. 2006, 12 (1): 81-7.CrossRefPubMed
11.
Markel H, Lipman HB, Navarro JA, Sloan A, Michalsen JR, Stern AM, Cetron MS: Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. Jama. 2007, 298 (6): 644-54. 10.1001/jama.298.6.644.CrossRefPubMed
12.
13.
Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD: Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA. 2004, 101 (5): 1356-61. 10.1073/pnas.0308352100.CrossRefPubMedPubMedCentral
14.
Bosman A, Du Ry van Beest Holle M, Conyn - van Spaendonck MAE, Koopmans MPG: Compliance amoung poultry workers to infection control measures during a large epizootic of Avian Influenza in commercial poultry farms in The Netherlands. Bilthoven: RIVM/Instituut voor Psychotrauma; 2004. Report No.: 630940001/2004.
15.
Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND: Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007, 26 (2): 136-45. 10.1037/0278-6133.26.2.136.CrossRefPubMed
16.
Kahneman D: Experiences of collaborative research. American Psychologist. 2003, 58 (9): 723-730. 10.1037/0003-066X.58.9.723.CrossRefPubMed
17.
Kahneman D, Slovic P, Tversky A: Judgement under uncertainty. Heuristics and biases. 1982, Cambridge: Cambridge University PressCrossRef
18.
19.
Slovic P: Trust, emotion, sex, politics, and science: Surveying the risk-assessment battlefield. Risk Analysis. 1999, 19 (4): 689-701.PubMed
20.
Slovic P: The Perception of Risk. 2000, London: Earthscan
21.
Joffe H: Risk: from perception to social representation. Br J Soc Psychol. 2003, 42 (Pt 1): 55-73. 10.1348/014466603763276126.CrossRefPubMed
22.
Beck U: Risk society. Towards a new modernity. 1992, London: Sage
23.
Rogers RW: A protection motivation theory of fear appeals and attitude change. Journal of Psychology. 1975, 91: 93-114.CrossRef
24.
Rogers RW: Cognitive and physiological processes in fear appeals and attitude change: A revised theory of protection motivation. 1983, New York: Guilford Press
25.
Sjoberg L: Worry and risk perception. Risk Anal. 1998, 18 (1): 85-93. 10.1111/j.1539-6924.1998.tb00918.x.CrossRefPubMed
26.
Weinstein ND: Why it won't happen to me: perceptions of risk factors and susceptibility. Health Psychol. 1984, 3 (5): 431-57. 10.1037/0278-6133.3.5.431.CrossRefPubMed
27.
Weinstein ND: The precaution adoption process. Health Psychology. 1988, 7 (4): 355-386. 10.1037/0278-6133.7.4.355.CrossRefPubMed
28.
Rippetoe PA, Rogers RW: Effects of components of protection-motivation theory on adaptive and maladaptive coping with a health threat. J Pers Soc Psychol. 1987, 52 (3): 596-604. 10.1037/0022-3514.52.3.596.CrossRefPubMed
29.
Ruiter RAC, Abraham C, Kok G: Scary warnings and rational precautions: a review of the psychology of fear appeals. Psychology and Health. 2001, 16: 613-630. 10.1080/08870440108405863.CrossRef
30.
Sadique MZ, Edmunds WJ, Smith RD, Meerding WJ, de Zwart O, Brug J, Beutels P: Precautionary behavior in response to perceived threat of pandemic influenza. Emerg Infect Dis. 2007, 13 (9): 1307-13.CrossRefPubMedPubMedCentral
31.
Lau JT, Kim JH, Tsui HY, Griffiths S: Anticipated and current preventive behaviors in response to an anticipated human-to-human H5N1 epidemic in the Hong Kong Chinese general population. BMC Infect Dis. 2007, 7: 18-10.1186/1471-2334-7-18.CrossRefPubMedPubMedCentral
32.
Blendon RJ, Benson JM, DesRoches CM, Raleigh E, Taylor-Clark K: The public's response to severe acute respiratory syndrome in Toronto and the United States. Clin Infect Dis. 2004, 38 (7): 925-31. 10.1086/382355.CrossRefPubMed
33.
Brug J, Aro AR, Oenema A, de Zwart O, Richardus JH, Bishop GD: SARS risk perception, knowledge, precautions, and information sources, the Netherlands. Emerg Infect Dis. 2004, 10 (8): 1486-9.CrossRefPubMedPubMedCentral
34.
Lau JT, Yang X, Tsui H, Kim JH: Monitoring community responses to the SARS epidemic in Hong Kong: from day 10 to day 62. J Epidemiol Community Health. 2003, 57 (11): 864-70. 10.1136/jech.57.11.864.CrossRefPubMedPubMedCentral
35.
Leung GM, Ho LM, Chan SK, Ho SY, Bacon-Shone J, Choy RY, Hedley AJ, Lam TH, Fielding R: Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong. Clin Infect Dis. 2005, 40 (12): 1713-20. 10.1086/429923.CrossRefPubMed
36.
Leung GM, Lam TH, Ho LM, Ho SY, Chan BH, Wong IO, Hedley AJ: The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong. J Epidemiol Community Health. 2003, 57 (11): 857-63. 10.1136/jech.57.11.857.CrossRefPubMedPubMedCentral
37.
Kristiansen IS, Halvorsen PA, Gyrd-Hansen D: Influenza pandemic: perception of risk and individual precautions in a general population. Cross sectional study. BMC Public Health. 2007, 7 (147): 48-10.1186/1471-2458-7-48.CrossRefPubMedPubMedCentral
38.
Gupta RK, Toby M, Bandopadhyay G, Cooke M, Gelb D, Nguyen-Van-Tam JS: Public understanding of pandemic influenza, United Kingdom. Emerg Infect Dis. 2006, 12 (10): 1620-1.CrossRefPubMedPubMedCentral
39.
40.
Lau JT, Tsui H, Kim JH, Griffiths S: Perceptions about status and modes of H5N1 transmission and associations with immediate behavioral responses in the Hong Kong general population. Prev Med. 2006, 43 (5): 406-10. 10.1016/j.ypmed.2006.06.007.CrossRefPubMed
41.
Lau JT, Kim JH, Tsui H, Griffiths S: Perceptions related to human avian influenza and their associations with anticipated psychological and behavioral responses at the onset of outbreak in the Hong Kong Chinese general population. Am J Infect Control. 2007, 35 (1): 38-49. 10.1016/j.ajic.2006.07.010.CrossRefPubMed
42.
de Zwart O, Veldhuijzen IK, Elam G, Aro AR, Abraham T, Bishop GD, Richardus JH, Brug J: Avian influenza risk perception, Europe and Asia. Emerg Infect Dis. 2007, 13 (2): 290-3. 10.3201/eid1302.060303.CrossRefPubMedPubMedCentral
43.
Gustafson PE: Gender differences in risk perception: theoretical and methodological perspectives. Risk Anal. 1998, 18 (6): 805-11. 10.1023/B:RIAN.0000005926.03250.c0.CrossRefPubMed
44.
Broek IVFvd, Koedijk FDH, van Veen MG, Op de Coul ELM, Sighem AI, Sande van der MAB: Sexually transmitted infections, including HIV, in the Netherlands in 2007. 2008, Bilthoven: RIVM, Report No.: RIVM Rapport 210261004
45.
Erkens CGM, SKalisvaart NA, Slump E, Sebek M, van Soolingen D: 'Tuberculose in Nederland 2007'. Surveillancerapport over de tuberculosesituatie in Nederland. 2009, Den Haag: KNCV Tuberculosefonds
46.
Chapman GB, Coups EJ: Emotions and preventive health behavior: worry, regret, and influenza vaccination. Health Psychol. 2006, 25 (1): 82-90. 10.1037/0278-6133.25.1.82.CrossRefPubMed
47.
Conner M, Norman P: Predicting Health Behaviour. 2005, Maidenhead: Open University Press
48.
Rosenstock IM: Historical origins of the health belief model. Health Education Monographs. 1974, 2: 1-8.
Metadata
Title
Monitoring of risk perceptions and correlates of precautionary behaviour related to human avian influenza during 2006 - 2007 in the Netherlands: results of seven consecutive surveys
Authors
Onno de Zwart
Irene K Veldhuijzen
Jan Hendrik Richardus
Johannes Brug
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-114

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue

Research article

High prevalence of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar

Research article

Distinct genotypic profiles of the two major clades of Mycobacterium africanum

Research article

Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia

Research article

Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy

Research article

Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis

Research article

Microsatellite typing and susceptibilities of serial Cryptococcus neoformansisolates from Cuban patients with recurrent cryptococcal meningitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits